NURO (NeuroMetrix Corp) Gross Profit Margin

NURO (NeuroMetrix Corp) - company brandmark

Sales of Quell neurostimulators and diagnostic systems for neurologists ensure stable demand, confirming the sector's macro-resilience driven by insurance payouts. The share of gross income in revenue visualizes current profitability, with the 55.40 mark reflecting the latest data. However, a deep operational crisis and reliance on a single product are forcing NeuroMetrix, Inc. (NURO) to liquidate assets to preserve capital.

NURO - NeuroMetrix Corporation Return on Gross Profit over the range 07/04/2022 - 05/11/2025

Analytical breakdowns and data insights for company NeuroMetrix (NURO)

- price and consensus price forecast:
- business market valuation indicators:
Fundamental valuation:NURO NeuroMetrix Corp
Mass-produced product of neurometrix.com

NeuroMetrix, Inc. (NURO) relies on organic resource optimization and limited retail sales of medical devices, which determines its current operational efficiency. This ratio digitizes the portion of revenue remaining after covering direct production costs, revealing the actual profitability of each unit. Analyzing the gross margin vector allows for the filtering of information noise and an assessment of the business's fundamental stability without relying on management declarations.

Key competitors

Return on Gross Profit Intuitive|Gross Profitability Danaher Corp.|Gross Return on Sales BDX (Becton Dickinson & Co)|Return on Gross Profit STE (STERIS Corporation)|Gross Profit Ratio WST|Gross Profitability Baxter International Inc. BAX|Gross Profit Ratio MASI (Masimo Corp)|STVN - Gross Profitability|Teleflex Inc - Gross Profit Ratio|merit.com (MMSI) - Gross Profitability|Gross Profit Margin envistaco.com (NVST)|ICUI (ICU Medical Inc) - Gross Margin|Gross Profit Margin Dentsply Sirona Inc XRAY|Gross Profitability LeMaitre Corp (LMAT)|ATRC (AtriCure Corp) - Gross Profit Rate|Gross Margin STAA (STAAR Surgical Co)|ChromaDex Corporation (NAGE) - Gross Profit Margin|ZimVie Inc - Gross Margin|Gross Profit Margin AngioDynamics|CERS (Cerus Corp) - Return on Gross Profit|Alpha Teknova, Inc. - Gross Profit Rate|MGRM (Monogram Orthopedics Inc.) - Gross Margin|STSS: Gross Profit Rate|Return on Gross Profit INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Gross Return on Sales|Gross Margin KRMD (korumedical.com)|Return on Sales by Gross Profit Nyxoah, S.A. (NYXH)|MBOT - Gross Profitability|PDEX (Pro-Dex, Inc.) - Gross Return on Sales|ZTEK (Zentek Ltd) - Return on Gross Profit|ELUT - Return on Sales by Gross Profit|MLSS (Milestone Scientific Corporation) - Gross Margin|Gross Return on Sales NXGL (NEXGEL, Inc.)|Gross Margin RVP|Return on Gross Profit Harvard Bioscience HBIO|Gross Margin FEMY (Femasys Corporation)|MHUA - Return on Gross Profit|POAI - Gross Profitability|Callan JMB (CJMB) - Return on Gross Profit|ATRI: Gross Margin